Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Core Viewpoint - Pfizer reported a decline in fourth-quarter sales due to decreasing demand for its Covid-19 vaccine and antiviral drug [1] Group 1: Company Performance - Pfizer's fourth-quarter sales were lower compared to previous periods, indicating a significant drop in revenue from Covid-19 related products [1]